Skip to main content
Intermediate Technical In the Industry Vocabulary Test

vivitrol

Pronunciation: VIV-ih-trol

Extended-release injectable form of naltrexone used for opioid and alcohol use disorder treatment.

Full Definition

Vivitrol is a brand name for extended-release naltrexone administered as a monthly intramuscular injection. This formulation provides sustained opioid and alcohol receptor blockade for approximately 28 days, eliminating daily medication compliance issues. Vivitrol is indicated for both opioid use disorder (after complete detoxification) and alcohol use disorder as part of comprehensive treatment programs. The injection must be administered by healthcare professionals and requires patients to be opioid-free for 7-14 days before initiation to avoid precipitated withdrawal.

Usage

Usage note: Capitalize as brand name; specify as injection form when distinguishing from oral naltrexone.

In Context

  • "The patient elected to start Vivitrol after completing a 14-day abstinence period." — Treatment plan documentation
  • "Insurance pre-authorization is typically required for Vivitrol due to its high cost." — Prior authorization request

Also known as

extended-release naltrexone naltrexone XR

Contrasted with

oral naltrexone daily medication

Don't confuse with

naloxone oral naltrexone buprenorphine

Editors from these organizations have used our services since 1998

Reuters BBC Oxford University Press Penguin Random House Springer Microsoft Suncor Energy United Nations Fisher Investments IBM The Home Depot KODAK CHEVRON